alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
[Federal Register Volume 60, Number 63 (Monday, April 3, 1995)]
[Notices]
[Page 16879]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-8106]



=======================================================================
-----------------------------------------------------------------------

FEDERAL DEPOSIT INSURANCE CORPORATION


Information Collection Submitted to OMB for Review

AGENCY: Federal Deposit Insurance Corporation.

ACTION: Extension of comment period on proposed revisions to Country 
Exposure Report (FFIEC 009).

-----------------------------------------------------------------------

SUMMARY: On March 16, 1995, the FDIC requested comment on proposed 
revisions to the Country Exposure Report (FFIEC 009). The Federal 
Financial Institutions Examination Council (FFIEC) proposed to 
implement the report as of March 31, 1995. However, the FFIEC has asked 
that the comment period be extended to give the public additional time 
to provide comment. In addition, the implementation date of the 
proposed revisions to the reporting form will be delayed until not 
earlier than September 30, 1995, to provide institutions with 
additional time to modify their systems and to resolve conceptual 
issues related to the report.

DATES: Comments must be received by April 21, 1995.

OMB REVIEWER: Milo Sunderhauf, (202) 395-7340, Office of Management and 
Budget, Paperwork Reduction Project 3064-0017, Washington, DC 20503.

FDIC CONTACT: Steven F. Hanft, (202) 898-3907, Office of the Executive 
Secretary, room F-400, Federal Deposit Insurance Corporation, 550 17th 
Street NW., Washington, DC 20429.

ADDRESSES: A copy of the submission may be obtained by calling or 
writing the FDIC contact identified above. Comments regarding the 
submission should be addressed to both the OMB reviewer and the FDIC 
contact.

SUPPLEMENTARY INFORMATION: On March 16, 1995 (60 FR 14285), the FDIC 
invited comment on proposed revisions to the Country Exposure Report 
(FFIEC 009). The FFIEC has received a request to extend the comment 
period and delay the implementation date of the proposed revisions. In 
view of the significance of the new items that are proposed in the 
report, the FDIC is extending the comment period to April 21, 1995, and 
delaying the proposed implementation date to not earlier than September 
30, 1995.

    Dated: March 29, 1995.

    Federal Deposit Insurance Corporation.
Steven F. Hanft,
Assistant Executive Secretary (Administration).
[FR Doc. 95-8106 Filed 3-31-95; 8:45 am]
BILLING CODE 6714-01-P
[Federal Register Volume 60, Number 71 (Thursday, April 13, 1995)]
[Notices]
[Page 18856]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-9112]



-----------------------------------------------------------------------


DEPARTMENT OF JUSTICE

Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--BP Chemicals, Inc.

    Notice is hereby given that, on February 3, 1995, pursuant to 
Section 6(a) of the National Cooperative Research and Production Act of 
1993, 15 U.S.C. 4301 et seq. (``the Act''), BP Chemicals, Inc., for 
itself and on behalf of its members, has filed written notification 
simultaneously with the Attorney General and the Federal Trade 
Commission disclosing (1) the identities of the parties and (2) the 
nature and objectives of the venture. The notifications were filed for 
the purpose of invoking the Act's provisions limiting recovery of 
antitrust plaintiffs to actual damages under specified circumstances. 
Pursuant to Section 6(b) of the Act, the identities of the parties are: 
BP Chemicals, Inc., Cleveland, OH; Praxair, Inc., Tonawanda, NY; and 
SSC, Inc., Woodinvale, WA. BP's general area of planned activity is to 
engage in an interactive cooperative research and development effort, 
funded in part by a grant from the National Institute of Standards and 
Technology Advanced Technology Program, relating to material 
development and testing, element and module development, modeling and 
process/system development and ion/electron conducting ceramic 
membranes. These membranes are expected to find application in 
industrial gas production and chemicals production. The grant is 
expected to run for four years commencing on about March 1, 1995.
Constance K. Robinson,
Director of Operations, Antitrust Division.
[FR Doc. 95-9112 Filed 4-12-95; 8:45 am]
BILLING CODE 4410-01-M
MI* Xt*Iitik 

tit TG53 . 1 5 

000000009 [290 1g 

00/T1804-2000 

>30-120 >120-460 >400-1000 >1000-2000 >2000-4000 

±0.30 ± 0.50 ±0.60 ± 1.20 ± 2.00 

#MF3 

3855.a 

R.-4-511 0.5-3 >3-6 >6-30 

4101 #0.10 ±0.10 ± 0.20 

4-84V. 

1-20 

t 4 4 B1 10531 500000000
exhibit10_12.htm


 







 


Exhibit 10.12


 


 



AMENDMENT TO LICENSE AGREEMENT


 


This Amendment ("Amendment'"). effective as of ________, 2011. modifies the terms of the License Agreement ("Agreement") between BioZone Laboratories. Inc. and BetaZone Laboratories LLC dated November 7. 2006.


 


Whereas:


 



	
A.

	
BioZone Phamlaceutical. Inc .. a Delaware corporation having a principal place of business at 580 Garcia Avenue. Pittsburg. CA 94565 ("BPI") is the successor in interest to BioZone Laboratories. Inc. ("BU") and the assignee of the BLI’s entire interest under the Agreement:







 



	
B.

	
BetaZone Laboratories LLC ("BetaZone") has developed the ophthalmic products listed in the attached schedule ("Existing Ophthalmic Products") pursuant to the Agreement: and







 



	
C.

	
BLI wishes to enter into a new separate license agreement relating to ophthalmic products with a third party;







 


Therefore. BPI and BetaZone agree as follows.


 



	
1.

	
BetaZone shall have the right to continue to market and sell Existing Ophthalmic Products pursuant to the Agreement. Such right shall include all other rights necessary to implement such marketing and sales activity. including the right to continue manufacture of Existing Ophthalmic Products pursuant to the Agreement.







 



	
2.

	
BetaZone shall not develop. market or sell any new therapeutic and/or preventative ophthalmic products incorporating the confidential information and/or Know-How as defined in the Agreement.







 







 



	
Signed:

	  	  
	
/s/ Camillo Rey

	  	
/s/ Brian Keller


	
Managing Director

	  	
CEO


	
BetaZone

	  	
BPI


	  	  	  
	
04/04/2011

	  	  
	
Date

	  	
Date
Order entered October 27, 2015

In The

Court of Appeals 

Fifth District of Texas at Dallas 

No. 05-15-00895-CR

No. 05-15-00896-CR

JAMES JOSEPH ASHBY, Appellant

V.

THE STATE OF TEXAS, Appellee

On Appeal from the Criminal District Court No. 1

Dallas County, Texas

Trial Court Cause Nos. F06-01322-H, F06-68733-H

ORDER

The Court ORDERS the trial court to make findings of fact regarding whether appellant 

has been deprived of the reporter’s record because of ineffective counsel, indigence, or for any 

other reason.

 The trial court shall first determine whether appellant desires to prosecute the appeals. If 

the trial court determines that appellant does not desire to prosecute the appeals, it shall 

make a finding to that effect.

 If the trial court determines that appellant desires to prosecute the appeals, it shall next 

determine whether appellant is indigent and entitled to proceed without payment of costs 

for the reporter’s record. If appellant is entitled to proceed without payment of costs, the 

trial court shall make a finding to that effect. Moreover, if appellant is indigent, the trial 

court is ORDERED to take such measures as may be necessary to assure effective 

representation, which may include appointment of new counsel. If the trial court finds 

appellant is not indigent, it shall determine whether retained counsel has abandoned the 

appeals.
 The trial court shall next determine: (1) the name and address of each court reporter who 

recorded the proceedings in this cause; (2) the court reporter’s explanation for the delay 

in filing the reporter’s record; and (3) the earliest date by which the reporter’s record can 

be filed. 

We ORDER the trial court to transmit a record, containing the written findings of fact, 

any supporting documentation, and any orders, to this Court within THIRTY DAYS of the date 

of this order.

The appeals are ABATED to allow the trial court to comply with this order. The appeals

shall be reinstated thirty days from the date of this order or when the findings are received, 

whichever is earlier.

/s/ CAROLYN WRIGHT

CHIEF JUSTICE
EXECUTIVE OFFICE OF THE PRESIDENT

OFFICE OF THE UNITED STATES TRADE REPRESENTATIVE

WASHINGTON, D.C. 20508

May 7, 2019

RE: Product Exclusion Request Number USTR-2018-0025-6961

General Motors:

The purpose of this letter is to inform you that the product exclusion request referenced 

above has been denied. As you are aware, USTR published a Federal Register notice (83 FR 

28710) on June 20, 2018, that announced the Trade Representative’s determination to impose an 

additional duty of 25 percent on certain products from China. On July 11, 2018, the Trade 

Representative published a Federal Register notice (83 FR 32181) which announced that a 

process had been established under which interested persons could request that products falling 

within a covered HTSUS subheading be excluded from the additional duties announced on June 

20.

Your request was reviewed in accordance with the factors and procedures set forth in 

Section B(1) of the July 11 notice. Based on that review, and after careful consideration, your 

request was denied because the request failed to show that this particular product is available 

only from China.

Because USTR will grant exclusion requests on a product specific basis, you may still 

benefit from a product exclusion if a similar product is granted an exclusion. Products for which 

an exclusion has been granted will be periodically announced on the USTR website. Product 

exclusions will become legally effective once published in the Federal Register. 

Sincerely,

Joseph Barloon

General Counsel
Exhibit 32.1

Certification of CEO Pursuant to

18 U.S.C. Section 1350,

As Adopted Pursuant to

Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Annual Report on Form 10-K of First State Bancorporation, a New
Mexico corporation (the "Company"), for the period ended December 31, 2006, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Michael R. Stanford, as President and Chief Executive Officer of the Company,
hereby certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

A signed original of this written statement required by Section 906 has been provided to First State Bancorporation and will be retained by First State Bancorporation and furnished to the Securities and Exchange
Commission or its staff upon request.



|                                     
|-------------------------------------
|/s/ Michael R. Stanford              
|Michael R. Stanford                  
|President and Chief Executive Officer
|February 28, 2007                    

This certification accompanies the Report pursuant to §906 of the Sarbanes-Oxley Act of 2002 and shall not,
except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of §18 of the Securities Exchange Act of 1934, as amended.
#### Wilbert K. SMITH, Appellant, v. STATE of Missouri, Respondent.

No. 67277.

Missouri Court of Appeals, Eastern District, Division One.

May 23, 1995.

Motion for Rehearing and/or Transfer to Supreme Court Denied June 26, 1995.

David C. Hemingway, Asst. Public Defender, St. Louis, for appellant.

Jeremiah W. (Jay) Nixon, Atty. Gen., Becky Owenson Kilpatrick, Asst. Atty. Gen., Jefferson City, for respondent.

Before REINHARD, P.J., and GARY M. GAERTNER and CRAHAN, JJ.

*ORDER*

PER CURIAM.

Appellant, Wilbert K. Smith, appeals from a denial by the Circuit Court of St. Louis County of his Rule 24.035 motion without an evidentiary hearing. We affirm.

We have reviewed the briefs of the parties and the legal file and find the order of the circuit court is not clearly erroneous. As we further find no jurisprudential purpose would be served by a written opinion, we affirm the *238circuit court’s order pursuant to Rule 84.16(b).
**Exhibit 21.1**

**Subsidiaries of Registrant**

 
| **SUBSIDIARY**                                     |   | **JURISDICTION OF INCORPORATION**   |
|----------------------------------------------------|--------|-------------------------------------|
|                                               |   |                                |
| Cymer (Barbados) Ltd.                              |   | Barbados                            |
|                                               |   |                                |
| Cymer B.V.                                         |   | Netherlands                         |
|                                               |   |                                |
| Cymer International, Ltd.                          |   | Barbados                            |
|                                               |   |                                |
| Cymer Japan, Inc.                                  |   | Japan                               |
|                                               |   |                                |
| Cymer Korea, Inc.                                  |   | Korea                               |
|                                               |   |                                |
| Cymer Singapore Pte Ltd.                           |   | Singapore                           |
|                                               |   |                                |
| Cymer Southeast Asia, Ltd.                         |   | Taiwan                              |
|                                               |   |                                |
| Cymer Semiconductor Equipment (Shanghai)  Co., Ltd |   | the People’s Republic of China |

 

----
exv10w1









    Exhibit 10.1



 




    Berggruen
    Acquisition Holdings Ltd.

    1114 Avenue of the Americas

    New York, New York 10036



 




    and



 




    Marlin
    Equities II, LLC

    555 Theodore Fremd Avenue

    Suite B-302

    Rye, New York 10580



 



    Liberty Acquisition Holdings Corp.




    1114 Avenue of the Americas, 41st Floor




    New York, New York 10036



 




    Date:
    May 7, 2010
    



 



		
	
    RE:  
	
    Securities
    Surrender Agreement




 



    Gentlemen:



 



    Reference is made to the Business Combination Agreement, dated
    as of March 5, 2010, as amended by Amendment Nos. 1, 2 and
    3 thereto (the “Business Combination
    Agreement”), by and among Liberty Acquisition Holdings
    Corp. (“Liberty”), Liberty Acquisition Holdings
    Virginia, Inc. and Promotora de Informaciones, S.A.
    (“Prisa”). Unless otherwise defined herein,
    capitalized terms are used herein as defined in the Business
    Combination Agreement.



 



    Pursuant to Section 9.19 of the Business Combination
    Agreement, Liberty has agreed to acquire from the Sponsors an
    aggregate of 3,000,000 shares of Liberty Common Stock for
    an aggregate purchase price of $300 and, pursuant to
    Section 10.3(g) of the Business Combination Agreement, it
    is a condition precedent to the obligations of Prisa that
    Liberty shall have completed such acquisition. To that end, each
    Sponsor hereby agrees to sell to Liberty, and Liberty agrees to
    purchase, an aggregate of 1,500,000 shares of Liberty
    Common Stock for a total purchase price to each Sponsor of $150.
    Such sale and purchase shall take place immediately prior to the
    Reincorporation Effective Time (and in all events after the vote
    at the Liberty Stockholder Meeting).



 



    Each of the parties hereto agrees that Prisa is intended to be,
    and shall be, a third party beneficiary under this letter
    agreement and shall be entitled to directly enforce
    Liberty’s rights hereunder.



 



    The obligations of the parties hereunder shall terminate if the
    Business Combination Agreement shall be terminated for any
    reason (other than the failure of the condition specified in
    Section 10.3(g) of the Business Combination Agreement).



 



    -signature page to follow-





    

    1








 







    Please acknowledge your agreement with the foregoing by
    executing this letter in the space provided below.



 



    Yours faithfully,



 



    Berggruen Acquisition Holdings Ltd.



 


			
	 	    By: 
	
    /s/  Jared
    Bluestein









    Name:     Jared Bluestein



			
	 	    Title: 
	
    Secretary




 



    Marlin Equities II, LLC



 


			
	 	    By: 
	
    /s/  Martin
    Franklin









    Name:     Martin Franklin



			
	 	    Title: 
	
    Authorized Signatory




 








    Acknowledged and Agreed:



 



    Liberty Acquisition Holdings Corp.



 







		
	    By: 	
    /s/  Jared
    Bluestein









    Name:     Jared Bluestein



		
	    Title: 	
    Secretary






    

    2
EXECUTIVE OFFICE OF THE PRESIDENT

OFFICE OF THE UNITED STATES TRADE REPRESENTATIVE

WASHINGTON, D.C. 20508

September 26, 2019

RE: Product Exclusion Request Number USTR-2018-0025-6115

Peabody Energy Corporation:

The purpose of this letter is to inform you that the product exclusion request referenced 

above has been denied. As you are aware, USTR published a Federal Register notice (83 FR 

28710) on June 20, 2018, that announced the Trade Representative’s determination to impose an 

additional duty of 25 percent on certain products from China. On July 11, 2018, the Trade 

Representative published a Federal Register notice (83 FR 32181) which announced that a 

process had been established under which interested persons could request that products falling 

within a covered HTSUS subheading be excluded from the additional duties announced on June 

20.

Your request was reviewed in accordance with the factors and procedures set forth in 

Section B(1) of the July 11 notice. Based on that review, and after careful consideration, your 

request was denied because the request did not contain a sufficient product identification or was 

determined to be non-administrable.

Because USTR will grant exclusion requests on a product specific basis, you may still 

benefit from a product exclusion if a similar product is granted an exclusion. Products for which 

an exclusion has been granted will be periodically announced on the USTR website. Product 

exclusions will become legally effective once published in the Federal Register. 

Sincerely,

Joseph Barloon

General Counsel
Exhibit 32.2













CERTIFICATION PURSUANT TO 18 U.S.C. Section 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002





In connection with the Quarterly Report of Lucas Energy, Inc. on Form 10-Q for the three months ended September 30, 2010, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, John O'Keefe, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge and belief: (1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and (2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.























/s/John O’Keefe


John O’Keefe


Chief Financial Officer


November 15, 2010
EXECUTIVE OFFICE OF THE PRESIDENT

OFFICE OF THE UNITED STATES TRADE REPRESENTATIVE

WASHINGTON, D.C. 20508

February 19, 2019

RE: Product Exclusion Request Number: USTR-2018-0025-6235

BorgWarner, Inc:

The purpose of this letter is to inform you that the product exclusion request referenced 

above has been denied. As you are aware, USTR published a Federal Register notice (83 FR 

28710) on June 20, 2018, that announced the Trade Representative’s determination to impose an 

additional duty of 25 percent on certain products from China. On July 11, 2018, the Trade 

Representative published a Federal Register notice (83 FR 32181) which announced that a 

process had been established under which interested persons could request that products falling 

within a covered HTSUS subheading be excluded from the additional duties announced on June 

20.

Your request was reviewed in accordance with the factors and procedures set forth in 

Section B(1) of the July 11 notice. Based on that review, and after careful consideration, your 

request was denied because the request concerns a product strategically important or related to 

‘‘Made in China 2025’’ or other Chinese industrial programs.

Because USTR will grant exclusion requests on a product specific basis, you may still 

benefit from a product exclusion if a similar product is granted an exclusion. Products for which 

an exclusion has been granted will be periodically announced on the USTR website. Product 

exclusions will become legally effective once published in the Federal Register. 

Sincerely,

Stephen P. Vaughn

General Counsel